Background The continual reassessment method (CRM) is an adaptive model-based
design used to estimate the maximum tolerated dose in dose finding clinical trials. A way to …

Traditional designs for phase I clinical trials require each patient (or small group of patients)
to be completely followed before the next patient or group is assigned. In situations such as …

BACKGROUND Although convalescent plasma has been widely used to treat severe
coronavirus disease 2019 (COVID-19), data from randomized controlled trials that support its …

This exploratory study was designed to identify the factors predictive of participation in
postsecondary education for high school leavers with autism. A secondary data analysis of the …

This study aimed to identify the factors associated with participation in employment for high
school leavers with autism. A secondary data analysis of the National Longitudinal Transition …

As clinicians begin to realize the important role of dose-finding in the drug development
process, there is an increasing openness to" novel" methods proposed in the past two decades. …

Background The prognosis for children with recurrent/refractory sarcomas is poor. We
determined the overall response rate (ORR) and overall survival (OS) of children with recurrent/…

Background and Purpose— An excess incidence of strokes among blacks versus whites has
been shown, but data on disparities related to Hispanic ethnicity remain limited. This study …

This paper studies the coherence conditions of dose-finding methods in the context of phase
I clinical trials, where the objective is to estimate a targeted quantile of the unknown dose-…

A meta-analysis was performed to examine differences in IQ profiles between individuals
with Asperger’s disorder (AspD) and high-functioning autism (HFA). Fifty-two studies were …